了解结核后肺部疾病的谱和管理:综合性综述
1Medicine, Shri Madan Lal Khurana Chest Clinic, New Delhi, IND.
Cureus
|July 30, 2024
概括
结核病后的肺病 (PTLD) 在结核病 (TB) 治疗后会导致长期的肺损伤. 早期检测和管理是改善患者结果和减少公共卫生负担的关键.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 结核病后的肺病 (PTLD) 是一个重大的临床挑战,特别是在结核病 (TB) 负担较高的地区.
- 它是由结核病治疗后的残留肺损伤造成的,导致纤维化和支气管支炎等疾病.
研究的目的:
- 提供PTLD的全面审查,涵盖病原,临床方面,诊断,管理,结果和公共卫生影响.
- 突出全球理解和解决PTLD的重要性.
主要方法:
- 文献综述包括病原体,临床表现,诊断方式和管理策略.
- 对长期结果和公共卫生影响的分析.
主要成果:
- PTLD表现出各种症状,包括慢性咳和复发性感染,往往带来诊断挑战.
- 诊断依赖于放射性成像,肺功能测试和患者病史.
- 治疗包括药物治疗,康复和手术,根据肺损伤程度和并发症量身定制.
结论:
- 有效的PTLD管理需要采取多方面的方法,考虑肺损伤,并发病症和医疗保健准入.
- 通过结核病控制计划和早期检测进行预防对于减轻PTLD影响至关重要.
- 解决PTLD对于个体患者的福祉和全球公共卫生系统至关重要.
相关概念视频
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation


